NCT04596852

Brief Summary

Cerebral palsy (CP) refers to a group of movement and posture disorders responsible for activity limitation due to brain damage that occurs during fetal development or during the first year of a child's life. Given the multitude of treatment options available, the choice of treatment is a key determinant that greatly influences the potential for improvement in motor function. This choice is based in particular on a diagnosis resulting from the comparison of a Clinical Gait Analysis (CGA) and a clinical examination, carried out by a practitioner, aimed at evaluating as accurately as possible the deficiencies present in children with CP. During the latter examination, passive inter-segmental stiffness and spasticity, both limiting factors in the mobility of the child with CP, are assessed. However, there are significant uncertainties in these measurements, which depend, among other things, on the examiner's feelings. The enrichment of this clinical assessment therefore requires the introduction of quantitative and objective measures. Portable dynamometers are increasingly used to measure the resistance of a joint during passive solicitations. Thus, both passive inter-segmental stiffness and spasticity can be characterized using instrumental methods. However, in the majority of studies proposed in the literature, the biomechanical computational model used is not unified with that of the CGA, thus altering the approximation of the parameters measured on the table with those estimated during gait. However, in order to evaluate the extent to which these phenomena occur during gait, it is important to follow the same biomechanical calculation procedure. Thus, our team proposes a new dynamometric measurement protocol for passive inter-segmental stiffness and spasticity adapted to the PC child. Nevertheless, in order to guarantee the reliability of the measurements, manual dynamometric solicitation methods must follow standardized protocols, and their psychometric properties must be defined before they can be used in clinical practice. This is why we wish to study the reliability of this new solution for dynamometric quantification of passive inter-segmental stiffness and spasticity in children with CP.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 22, 2020

Completed
11 days until next milestone

Study Start

First participant enrolled

November 2, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2023

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 24, 2025

Status Verified

August 1, 2025

Enrollment Period

3 years

First QC Date

October 15, 2020

Last Update Submit

August 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Passive Stiffness Index

    A stiffness index representing the evolution of the resistance to passive stretch as a function of the angular amplitude. A higher score means that the joint is stiffer.

    2 years

  • Model deviation

    The root mean square deviation between the passive moment predicted by a passive stiffness model, defined at low velocity, and the passive moment measured at high velocity. A higher score means that the subject's spasticity is more important.

    2 years

Secondary Outcomes (2)

  • Electromyography Activity

    2 years

  • Joint Kinematics

    2 years

Study Arms (2)

Healthy children

EXPERIMENTAL
Device: Assessment of the reliability of a protocol characterizing intersegmental hyper-resistance to passive stretch

Children with cerebral palsy

EXPERIMENTAL
Device: Assessment of the reliability of a protocol characterizing intersegmental hyper-resistance to passive stretch

Interventions

Passive solicitations of the main joints of the lower limb, of healthy children and children with cerebral palsy, are realized by two evaluators with a handheld dynamometer. Repeated measures are performed to assess intra and inter-reliability.

Children with cerebral palsyHealthy children

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • A clinical diagnosis of CP noted in the medical record
  • An age between 7 and 18 years old
  • Levels I to III for the Global Motor Function Classification System (GMFCS)
  • Ability to cooperate, understand and follow simple instructions
  • Patient affiliated to the French social security system
  • Voluntary patient whose parents have given their consent to participate
  • An age between 7 and 18 years old
  • Ability to cooperate, understand and follow simple instructions
  • Patient affiliated to the French social security system
  • Voluntary patient whose parents have given their consent to participate

You may not qualify if:

  • Medical decision for any reason
  • Child or parent decision for any reason
  • Inability to cooperate, to understand and to follow instructions
  • Surgery or botulinum toxin injection within 6 months prior to the start of the study.
  • A diagnosis of a form of dystonia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Ellen Poidatz

Saint-Fargeau-Ponthierry, France

RECRUITING

Related Links

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Eric Desailly, PhD

    Fondation Ellen Poidatz

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
The order of participation of evaluators is random.
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2020

First Posted

October 22, 2020

Study Start

November 2, 2020

Primary Completion

November 2, 2023

Study Completion

December 31, 2025

Last Updated

August 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations